Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Augmented I/O for limited form factor user-interfaces
Chef's jacket
Phosphor mixture for a discharge lamp and a discharge lamp
Tampering monitoring system, management apparatus, and management method
Selective removal of on-die redistribution interconnects from scribe-lines
Golf shoe outsole
Electronic weighing device and server system
  Randomly Featured Patents
Process for the determination of peroxidase
Apparatus for inspection and repair of recording tape cassettes
Apparatus and method for determining a reference position for an industrial robot
Method of floating calcium carbonate ore and flotation reagent therefor
Multilayer wiring substrate
Surfactant waterflooding employing amphoteric sulfonium sulfonates
Information communication system, information processing apparatus, and operating terminal
Optical sensor for opaque and non-opaque materials
Financial services product training apparatus and method related thereto
Mounting assembly